Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
Nephrotoxic and Genotoxic N-Acetyl-S-Dichlorovinyl-L-Cysteine Is a Urinary Metabolite after Occupational 1,1,2-Trichloroethene Exposure in Humans: Implications for the Risk of Trichloroethene ExposureBirner, Gerhard ; Vamvakas, Spyridon ; Dekant, Wolfgang ; Henschler, DietrichEnvironmental health perspectives, 1993-03, Vol.99, p.281-284 [Periódico revisado por pares]United States: National Institute of Environmental Health Sciences. National Institutes of Health. Department of Health, Education and WelfareTexto completo disponível |
|
2 |
Material Type: Artigo
|
The role of cytochrome P4503A1/2 in the sex-specific sulfoxidation of the hexachlorobutadiene metabolite, N-acetyl-S-(pentachlorobutadienyl)-L-cysteine in ratsWerner, M ; Birner, G ; Dekant, WDrug metabolism and disposition, 1995-08, Vol.23 (8), p.861 [Periódico revisado por pares]United States: American Society for Pharmacology and Experimental TherapeuticsTexto completo disponível |
|
3 |
Material Type: Artigo
|
N-acetyl-S-(1,2,2-trichlorovinyl)-L-cysteine and 2,2,2-trichloroethanol: two novel metabolites of tetrachloroethene in humans after occupational exposureBIRNER, G ; RUTKOWSKA, A ; DEKANT, WDrug metabolism and disposition, 1996-01, Vol.24 (1), p.41-48 [Periódico revisado por pares]Bethesda, MD: American Society for Pharmacology and Experimental TherapeuticsTexto completo disponível |
|
4 |
Material Type: Artigo
|
QUANTITATION OF BISPHENOL A AND BISPHENOL A GLUCURONIDE IN BIOLOGICAL SAMPLES BY HIGH PERFORMANCE LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRYVÖLKEL, Wolfgang ; BITTNER, Nataly ; DEKANT, WolfgangDrug metabolism and disposition, 2005-11, Vol.33 (11), p.1748-1757 [Periódico revisado por pares]Bethesda, MD: American Society for Pharmacology and Experimental TherapeuticsTexto completo disponível |
|
5 |
Material Type: Artigo
|
Metabolism of hexafluoropropene. Evidence for bioactivation by glutathione conjugate formation in the kidneyKoob, M ; Dekant, WDrug metabolism and disposition, 1990-11, Vol.18 (6), p.911 [Periódico revisado por pares]United States: American Society for Pharmacology and Experimental TherapeuticsTexto completo disponível |
|
6 |
Material Type: Artigo
|
Liver abnormalities and hydrochlorofluorocarbonsAnders, MW ; Dekant, WolfgangThe Lancet (British edition), 1997-10, Vol.350 (9086), p.1249-1249 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
|
7 |
Material Type: Artigo
|
Gas-uptake pharmacokinetics of 2,2-dichloro-1,1,1-trifluoroethane (HCFC-123)LOIZOU, G. D ; URBAN, G ; DEKANT, W ; ANDERS, M. WDrug metabolism and disposition, 1994-07, Vol.22 (4), p.511-517 [Periódico revisado por pares]Bethesda, MD: American Society for Pharmacology and Experimental TherapeuticsTexto completo disponível |
|
8 |
Material Type: Artigo
|
Role of cytochrome P450 2E1 in the metabolism of 1,1,2,3,3,3-hexafluoropropyl methyl etherKöster, U ; Speerschneider, P ; Kerssebaum, R ; Wittmann, H ; Dekant, WDrug metabolism and disposition, 1994-09, Vol.22 (5), p.667-672 [Periódico revisado por pares]Bethesda, MD: American Society for Pharmacology and Experimental TherapeuticsTexto completo disponível |
|
9 |
Material Type: Artigo
|
Glutathione-dependent biosynthesis and bioactivation of S-(1,2-dichlorovinyl)glutathione and S-(1,2-dichlorovinyl)-L-cysteine, the glutathione and cysteine S-conjugates of dichloroacetylene, in rat tissues and subcellular fractionsNITA PATEL ; BIRNER, G ; DEKANT, W ; ANDERS, M. WDrug metabolism and disposition, 1994-01, Vol.22 (1), p.143-147 [Periódico revisado por pares]Bethesda, MD: American Society for Pharmacology and Experimental TherapeuticsTexto completo disponível |
|
10 |
Material Type: Artigo
|
Biotransformation of the aerosol propellant 1,1,1,2,3,3,3-heptafluoropropane (HFA-227): lack of protein binding of the metabolite hexafluoroacetoneU Köster ; D Mayer ; H M Deger ; W DeKantDrug metabolism and disposition, 1996-08, Vol.24 (8), p.906-910 [Periódico revisado por pares]Bethesda, MD: American Society for Pharmacology and Experimental TherapeuticsTexto completo disponível |